Center for Genetic Engineering & Biotechnology, Havana
CTL peptide and VSSP eradicates established HPV E7-expressing tumors
Published in Health Insurance Week, February 26th, 2006
According to recent research from Cuba, "Peptide-based vaccines aimed at the induction of effective T-cell responses against established tumors have not been successful in clinic and require the use of new adjuvants."
"One of those is a new adjuvant in which gangliosides are incorporated into the outer membrane protein complex of Neisseria meningitidis to form very small size proteoliposomes (VSSP)," said Isis Torrens and collaborators at the Center for Genetic Engineering and Biotechnology and Center of Molecular Immunology...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
More Articles from Health Insurance Week
- Health Management Associates, Inc.
Nonurban hospitals operator reports Q1 earnings; net patient service revenue grew 14.9% - Acacia Research Corp.
Biological arrays maker expands alliance with Inbio - Astellas Pharma
FK614, a novel PPAR gamma modulator, has potential antidiabetic properties - Ben Gurion University of Negev, Beer Sheva
Low-level laser irradiation stimulates osteogenic MSC phenotype seeded on 3D biomatrix - BioSphere Medical, Inc.
Uterine fibroid treatment developer reports 20% revenue growth - CHU Bichat, Paris
Ferumoxtran-10-enhanced MRI can quantify aortic macrophage infiltration - More from this issue of Health Insurance Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
